PEX19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.842200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.911450E-01
Normal-vs-Stage2
6.101800E-01
Normal-vs-Stage3
1.992040E-01
Normal-vs-Stage4
1.669790E-02
Stage1-vs-Stage2
4.875800E-01
Stage1-vs-Stage3
1.468390E-02
Stage1-vs-Stage4
1.336050E-01
Stage2-vs-Stage3
7.117700E-02
Stage2-vs-Stage4
8.664000E-02
Stage3-vs-Stage4
2.524200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.147600E-01
Normal-vs-AfricanAmerican
3.250800E-01
Normal-vs-Asian
5.296200E-01
Caucasian-vs-AfricanAmerican
7.827600E-01
Caucasian-vs-Asian
5.743000E-01
AfricanAmerican-vs-Asian
9.047200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.619800E-01
Normal-vs-Female
6.164400E-01
Male-vs-Female
8.163400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.601000E-01
Normal-vs-Age(41-60Yrs)
2.840800E-01
Normal-vs-Age(61-80Yrs)
7.126600E-01
Normal-vs-Age(81-100Yrs)
9.880400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.882800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.553800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.063700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.925600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.723500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.402190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.476800E-01
Normal-vs-Daily Drinker
9.542800E-01
Normal-vs-Weekly Drinker
7.933000E-01
Normal-vs-Occasional Drinker
1.783950E-01
Normal-vs-Social Drinker
5.589200E-01
Non Drinker-vs-Daily Drinker
9.921600E-01
Non Drinker-vs-Weekly Drinker
6.410200E-01
Non Drinker-vs-Occasional Drinker
5.377700E-03
Non Drinker-vs-Social Drinker
2.635400E-01
Daily Drinker-vs-Weekly Drinker
6.661600E-01
Daily Drinker-vs-Occasional Drinker
4.518800E-03
Daily Drinker-vs-Social Drinker
3.039800E-01
Weekly Drinker-vs-Occasional Drinker
4.596200E-02
Weekly Drinker-vs-Social Drinker
6.452200E-01
Occasional Drinker-vs-Social Drinker
8.830100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.999700E-02
Normal-vs-Grade 2
7.216300E-03
Normal-vs-Grade 3
3.437900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.235000E-01
Grade 1-vs-Grade 3
5.921400E-01
Grade 1-vs-Grade 4
8.999700E-02
Grade 2-vs-Grade 3
7.360200E-01
Grade 2-vs-Grade 4
7.216300E-03
Grade 3-vs-Grade 4
3.437900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.625200E-01
Normal-vs-NonDiabetic
5.813600E-01
Diabetic-vs-NonDiabetic
5.013600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.518600E-01
Normal-vs-NoPancreatitis
6.075400E-01
Pancreatitis-vs-NoPancreatitis
7.816800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.192600E-01
Normal-vs-N1
6.966000E-01
N0-vs-N1
5.276200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.211400E-01
Normal-vs-TP53-NonMutant
5.497000E-01
TP53-Mutant-vs-TP53-NonMutant
9.851400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
